Literature DB >> 32543980

Intralesional cryotherapy versus cryotherapy spray for the treatment of recalcitrant plantar warts: a prospective, randomized study.

Waleed Albalat1, Enayat Attwa1, Howyda Mohamed Ebrahim1.   

Abstract

BACKGROUND: Recalcitrant plantar warts are representing a therapeutic challenge. Intralesional cryotherapy (ILC) has emerged as a promising therapeutic option in recalcitrant plantar warts treatment.
OBJECTIVE: To compare the clinical efficacy, safety and tolerability of (ILC) versus Cryotherapy spray (Cryo-sp) for treatment of recalcitrant plantar warts.
METHODS: One hundred-thirty patients with recalcitrant plantar warts were assigned equally to two groups. Group A received ILC and group B treated with Cryo-SP. Both groups received one session at 2 weeks intervals until complete clearance or for a maximum of 5 sessions. The main outcome was complete clearance of warts guided by dermoscopy. Follow-up was carried out for 6 months after the treatment.
RESULTS: Complete clearance occurred in 80.3% in group A compared to 50.8% in group B with a highly significant difference between both groups (p < .001). The clearance rate was faster in group A (1.5 ± 0.40) than group B (4 ± 1.3) (p < .001). The adverse effects were mild in group A than group B (p < .001). The recurrence rate was 2% in group A versus 23.3% in group B (p < .007).patients satisfaction was higher in ILC (p < .001).
CONCLUSION: Intralesional cryotherapy is more effective, requiring few sessions with a low recurrence rate than cryo-sp.

Entities:  

Keywords:  Intralesional cryotherapy; cryosurgery; cryotherapy spray; dermoscopy; recalcitrant plantar warts

Mesh:

Year:  2020        PMID: 32543980     DOI: 10.1080/09546634.2020.1782821

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  1 in total

1.  Efficacy of cryotherapy for plantar warts: A systematic review and meta-analysis.

Authors:  Sara García-Oreja; Francisco Javier Álvaro-Afonso; Aroa Tardáguila-García; Mateo López-Moral; Marta García-Madrid; José Luis Lázaro-Martínez
Journal:  Dermatol Ther       Date:  2022-04-06       Impact factor: 3.858

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.